Kurz Michael | Aventis Pharma
スポンサーリンク
概要
関連著者
-
Kurz Michael
Aventis Pharma
-
Kurz Michael
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Kurz M
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Kurz M
Aventis Pharma Frankfurt Am Main Deu
-
Knauf M
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Vertesy Laszlo
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Seibert G.
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
SEIBERT Gerhard
Aventis Pharma Deutschland GmbH, Division Lead Generation
-
Schiell Matthias
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Paulus E.f.
Institut Fur Mineralogie/kristallographie Der Johann Wolfgang Goethe-universitat
-
Wink Joachim
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
SCHUMMER DIETMAR
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
Schummer Dietmar
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Hammann P
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
MARAZZI ALESSANDRA
Vicuron Pharmaceuticals via R. Lepetit
-
SELVA ENRICO
Vicuron Pharmaceuticals via R. Lepetit
-
Vogel Martin
Aventis Pharma Deutschland Gmbh Global Preclinical Development Analytics
-
Corti Emiliana
Vicuron Pharmaceuticals
-
Ehrlich Klaus
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Isert D
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Kurz Michael
Aventis Pharma Deutschland Gmbh-frankfurt Am Main Germany
-
Colombo Luigi
Vicuron Pharmaceuticals Via R. Lepetit
-
TOTI LUIGI
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
VERTESY Laszlo
LG Natural Product Research
-
Toti Luigi
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
HOFMANN Joachim
Intervet, Industriepark Hochst
-
SCHMIDT Frank
Aventis Pharma Deutschland GmbH, Process Development
-
Schmidt Frank
Aventis Pharma Deutschland Gmbh Process Development
-
Hofmann Joachim
Intervet Industriepark Hochst
-
CICILIATO ISMAELA
Vicuron Pharmaceuticals
-
SARUBBI EDOARDO
Aventis Pharma
-
STEFANELLI STEFANIA
IPIA G. Galilei
-
GASTALDO LUCIANO
Vicuron Pharmaceuticals
-
MONTANINI NICOLETTA
Vicuron Pharmaceuticals
-
LOSI DANIELE
Vicuron Pharmaceuticals
-
EDER CLAUDIA
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
ISERT DIETER
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
LI ZIYU
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
PAULUS ERICH
Institut fur Mineralogie/Kristallographie der Johann Wolfgang Goethe-Universitat
-
VERTESY Laszlo
Natural Product Research
-
PAULUS Erich
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
HAMMANN Peter
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
BECK Bernd
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
BRONSTRUP Mark
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
MULLER Gunter
Aventis Pharma Deutschland GmbH, Drug Innovation & Approval
-
Broenstrup M
Aventis Pharma Deutschland Gmbh Frankfurt/main Deu
-
Sarubbi E.
Vicuron Pharmaceuticals S.r.l
-
Stefanelli S
Ipia G. Galilei
-
Beck Bernd
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Gastaldo L
Vicuron Pharmaceuticals Italy S. R. L. Via R. Lepetit
-
Muller Gunter
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Ciciliato I
Vicuron Pharmaceuticals
-
Stefanelli Stefania
Via Wolkenstein
-
Marinelli Flavia
Dipartimento Di Biotecnologie E Scienze Molecolari Universita Dell' Insubria
-
Montanini N
Vicuron Pharmaceuticals
-
Li Ziyu
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
-
Eder Claudia
Aventis Pharma Deutschland Gmbh Drug Innovation & Approval
著作論文
- Cephaibols, New Peptaibol Antibiotics with Anthelmintic Properties from Acremonium tubakii DSM 12774
- Antibiotics GE23077, Novel Inhibitors of Bacterial RNA Polymerase : I. Taxonomy, Isolation and Characterization
- Ustilipids, Acylated β-D-Mannopyranosyl D-Erythritols from Ustilago maydis and Geotrichum candidum
- The Chemical Structure of Mumbaistatin, a Novel Glucose-6-phosphate Translocase Inhibitor Produced by Streptomyces sp. DSM 11641
- Cyclipostins, Novel Hormone-sensitive Lipase Inhibitors from Streptomyces sp. DSM 13381 II. Isolation, Structure Elucidation and Biological Properties
- Antibiotics GE23077, Novel Inhibitors of Bacterial RNA Polymerase : II. Structure Elucidation